Home › Funds › CONNING INC. › ABT

CONNING INC. position in ABT

ABBOTT LABORATORIES · Health Care

CONNING INC. reported holding 359,586 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$35.5M, representing 1.12% of its reported portfolio and ranking #48 among its reported holdings. CONNING INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)359.59K sh
Reported value held$35.54M
Portfolio Weight1.12%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CONNING INC.'s ABT position evolved

CONNING INC. first disclosed a stake in ABT in Q3 2023 at 332,655 shares (US$32.2M). The position peaked in Q2 2026 at 421,457 shares, worth US$38.2M. Across 13 filings, CONNING INC. increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 359,586 shares valued at US$35.5M — a reduction of -61,871 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 332.65K $32.16M New
Q4 2023 301.52K $33.12M Reduce
Q1 2024 304.58K $34.55M Add
Q2 2024 345.22K $35.81M Add
Q3 2024 331.53K $37.80M Reduce
Q4 2024 323.70K $36.61M Reduce
Q1 2025 259.59K $34.43M Reduce
Q2 2025 260.32K $35.41M Hold
Q3 2025 253.29K $33.93M Reduce
Q4 2025 274.47K $34.39M Add
Q1 2026 322.83K $33.14M Add
Q2 2026 421.46K $38.24M Add
Q3 2026 359.59K $35.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has CONNING INC. held ABT?

CONNING INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONNING INC.'s current position in ABT?

As of Q3 2026, CONNING INC. holds 359.59K shares of ABT (ABBOTT LABORATORIES), valued at $35.54M, representing 1.12% of its reported portfolio and ranking #48.

Has CONNING INC. been buying or selling ABT?

In the latest 13F filing (Q3 2026), CONNING INC. reduced its position in ABT. The position peaked in Q2 2026 at 421.46K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.